Navigation Links
bwin and Harvard Medical School Faculty Sign 5-Year Research Cooperation Agreement
Date:12/15/2008

VIENNA, Austria, December 15 /PRNewswire-FirstCall/ -- bwin, the world's leading online gaming company, and the Division on Addictions at the Cambridge Health Alliance, a Harvard Medical School Teaching Affiliate, have just signed an agreement for research collaboration for five years. The research objective is to use scientific evidence to create the safest possible online gaming environment by implementing the findings of the world's largest longitudinal study.

The Division on Addictions at the Cambridge Health Alliance, a Harvard Medical School Teaching Affiliate, has been working with bwin for the last three years setting new standards for the industry, developing and testing empirically-supported new responsible gaming initiatives, and providing customers with responsible gaming information and tools. This research has just been extended for another five years. The prime research objective is to establish a scientific evidence base that can guide the development of safe, recreational gaming environments and prevent the emergence of gaming-related problems as well as reduce any such problems that already exist.

"bwin has taken the industry's leading position for corporate social responsibility. Their commitment to the scientific process and unwillingness to take shortcuts to achieve short-term gains is noteworthy and indicative of its commitment to the health and welfare of its subscribers. Through its relationship with the Division on Addictions, bwin has supported numerous scientific inquiries, including the first ever scientific longitudinal study of actual internet gaming behavior, numerous scientific publications, and editorial position statements. bwin has integrated responsible gaming efforts into its business practices and made empirically-supported self-help resources available to its subscribers," says Dr. Howard Shaffer, Associate professor at Harvard Medical School and Director of the Division on Addictions.

The scientific studies analyzed the data of over 47,000 customers over a 36-month period, making it the largest longitudinal study of its kind worldwide. Because it relies on actual customer data and not self-reported results, the results are not influenced by customer recall or interpretation. The intention is to expand and enhance the responsible gaming activities into a systematic program of responsible gaming tools and applications.

"We need to understand what goes on in consumers' minds and be able to answer fundamental questions about online gaming based on scientific evidence - and not based on speculation. Ultimately, we are interested in creating behavioral models capable of predicting certain outcomes. Therefore, we are working towards establishing the scientific foundation that will yield algorithms capable of identifying risk patterns associated with disordered gambling so that we can prevent them," states Manfred Bodner, Co-CEO of bwin.

    For further inquiries:

    Press:

    Kevin O'Neal, Press Officer
    bwin Interactive Entertainment AG
    Borsegasse 11, 1010 Vienna, Austria
    Tel.: +43(0)50-858-24010
    E-mail: press@bwin.org

   http://www.bwin.ag

    Investors:

    Konrad Sveceny, Investor Relations
    bwin Interactive Entertainment AG
    Borsegasse 11, 1010 Vienna, Austria
    Tel.: +43(0)50-858-20017
    E-mail: investorrelations@bwin.org

   http://www.bwin.ag



'/>"/>
SOURCE bwin Interactive Entertainment AG
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Isilon CTO Addresses Life Science Data Storage Challenges at Harvard Medical Schools BioMedical HPC Leadership Summit
2. HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center
3. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
4. Egenix Licenses Harvard Anti-Cancer Platform
5. Harvard University engineers demonstrate quantum cascade laser nanoantenna
6. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
7. BioMS Medical recognized at Scrip Awards 2008
8. Oridion Announces Significant Medical Research to be Presented at AARC Congress
9. NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate
10. Life Science Alley: R&D Makes German Medical Technologies Top in Europe
11. ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
Breaking Biology Technology:
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
Breaking Biology News(10 mins):